Issue Brief: How Congress and States Should Respond to Electricity Price Spikes Due to the Iran War
March 31, 2026 — This issue brief explains why the Iran War threatens to cause severe electricity spikes by explaining the link between natural gas and electricity markets; the immediate threats from the ongoing war to utility procurements; and vulnerabilities in the Northeast region. The brief also points to lessons that elected officials and policymakers can draw from the aftermath of Russia’s invasion of Ukraine, in terms of electricity price impacts, especially during the 2022-2023 winter period, and outlines policy actions to protect consumers who are already suffering from high utility bills.
Morgan’s Monopoly Digest – March 2026
March 25, 2026 — March version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.
Paramount-Warner Bros. Discovery FAQ: What You Need to Know
March 18, 2026 — The proposed Paramount-Warner Bros. Discovery transaction will result in one of the most transformative changes to the entertainment landscape in decades if it goes through. It combines two large television, sports, and film conglomerates. There are financial, cultural, legal, political and labor impacts of the deal. The Department of Justice Antitrust Division (DOJ ATR), state attorneys general, and international enforcers all have the authority to intervene to block the merger. This document is intended to answer questions about the transaction.
Making Medicine in America Again: Why Breaking Monopolies Is Key to Building a Resilient U.S. Pharmaceutical Manufacturing Base
March 4, 2026 — This paper explains the risks of U.S. dependence on foreign countries for essential medicines and tells the history of how we got here, discusses how successful onshoring of pharmaceutical manufacturing requires restructuring markets by reining in the market power and anti-competitive practices of pharmaceutical middlemen, sets forth a vision and plan for incorporating antimonopoly by design to build deconcentrated pharmaceutical manufacturing market structures, and discusses trade policies to be implemented as competition policies restructure markets and as industrial policies invest in, and create reliable demand for, domestic manufacturing.
Model Legislation: The Just and Reasonable Utility Prices for Consumers and Businesses Act
February 17, 2026 — This model legislation provides immediate relief for utility customers by reining in unjust and unreasonable monopoly utility profits.
Morgan’s Monopoly Digest – Feb 2026
February 12, 2026 — February version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.